Q4 2021 13F Holders as of 31 Dec 2021
-
Type / Class
-
Equity / Common Stock, par value $0.0001 per share
-
Shares outstanding
-
87M
-
Number of holders
-
143
-
Total 13F shares, excl. options
-
64.1M
-
Shares change
-
-5.19M
-
Total reported value, excl. options
-
$898M
-
Value change
-
-$108M
-
Put/Call ratio
-
0.46
-
Number of buys
-
72
-
Number of sells
-
-63
-
Price
-
$14.00
Significant Holders of Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) as of Q4 2021
182 filings reported holding KURA - Kura Oncology, Inc. - Common Stock, par value $0.0001 per share as of Q4 2021.
Kura Oncology, Inc. - Common Stock, par value $0.0001 per share (KURA) has 143 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 64.1M shares
of 87M outstanding shares and own 73.69% of the company stock.
Largest 10 shareholders include FMR LLC (5.58M shares), BlackRock Inc. (5.1M shares), Avoro Capital Advisors LLC (4M shares), EcoR1 Capital, LLC (3.72M shares), SUVRETTA CAPITAL MANAGEMENT, LLC (3.57M shares), DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) (3.51M shares), STATE STREET CORP (3.38M shares), VANGUARD GROUP INC (3.27M shares), Deep Track Capital, LP (2.55M shares), and Holocene Advisors, LP (2.36M shares).
This table shows the top 143 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.